계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
CStone Pharmaceuticals
company
About
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $260M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Dec 23, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
CStone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative tumor immunotherapy and precision treatment drugs to meet the intensive medical needs of cancer patients in China and around the world.CStone Pharmaceuticals has assembled a world-class management team with extensive experience in new drug development, clinical research, and commercialization. The company has built a rich product pipeline composed of 15 tumor candidate drugs with the combination of tumor immunotherapy as the core.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$260M
CStone Pharmaceuticals has raised a total of
$260M
in funding over 2 rounds. Their latest funding was raised on
May 9, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 9, 2018 | Series B | $260M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
CStone Pharmaceuticals is funded by 2 investors.
ARCH Venture Partners
and King Star Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
